> top > docs > PubMed:18483878 > annotations

PubMed:18483878 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-154 Sentence denotes Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis.
T2 155-267 Sentence denotes Vasoactive intestinal polypeptide (VIP) is an immunomodulatory neuropeptide distributed in micturition pathways.
T3 268-414 Sentence denotes VIP(-/-) mice exhibit altered bladder function and neurochemical properties in micturition pathways after cyclophosphamide (CYP)-induced cystitis.
T4 415-572 Sentence denotes Given VIP's role as an anti-inflammatory mediator, we hypothesized that VIP(-/-) mice would exhibit enhanced inflammatory mediator expression after cystitis.
T5 573-799 Sentence denotes A mouse inflammatory cytokine and receptor RT2 profiler array was used to determine regulated transcripts in the urinary bladder of wild type (WT) and VIP(-/-) mice with or without CYP-induced cystitis (150 mg/kg; i.p.; 48 h).
T6 800-1032 Sentence denotes Four binary comparisons were made: WT control versus CYP treatment (48 h), VIP(-/-) control versus CYP treatment (48 h), WT control versus VIP(-/-) control, and WT with CYP treatment (48 h) versus VIP(-/-) with CYP treatment (48 h).
T7 1033-1184 Sentence denotes The genes presented represent (1) greater than 1.5-fold change in either direction and (2) the p value is less than 0.05 for the comparison being made.
T8 1185-1286 Sentence denotes Several regulated genes were validated using enzyme-linked immunoassays including IL-1beta and CXCL1.
T9 1287-1611 Sentence denotes CYP treatment significantly (p < or = 0.001) increased expression of CXCL1 and IL-1beta in the urinary bladder of WT and VIP(-/-) mice, but expression in VIP(-/-) mice with CYP treatment was significantly (p < or = 0.001) greater (4.2- to 13-fold increase) than that observed in WT urinary bladder (3.6- to 5-fold increase).
T10 1612-1750 Sentence denotes The data suggest that in VIP(-/-) mice with bladder inflammation, inflammatory mediators are increased above that observed in WT with CYP.
T11 1751-1925 Sentence denotes This shift in balance may contribute to increased bladder dysfunction in VIP(-/-) mice with bladder inflammation and altered neurochemical expression in micturition pathways.
T1 0-154 Sentence denotes Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis.
T2 155-267 Sentence denotes Vasoactive intestinal polypeptide (VIP) is an immunomodulatory neuropeptide distributed in micturition pathways.
T3 268-414 Sentence denotes VIP(-/-) mice exhibit altered bladder function and neurochemical properties in micturition pathways after cyclophosphamide (CYP)-induced cystitis.
T4 415-572 Sentence denotes Given VIP's role as an anti-inflammatory mediator, we hypothesized that VIP(-/-) mice would exhibit enhanced inflammatory mediator expression after cystitis.
T5 573-799 Sentence denotes A mouse inflammatory cytokine and receptor RT2 profiler array was used to determine regulated transcripts in the urinary bladder of wild type (WT) and VIP(-/-) mice with or without CYP-induced cystitis (150 mg/kg; i.p.; 48 h).
T6 800-1032 Sentence denotes Four binary comparisons were made: WT control versus CYP treatment (48 h), VIP(-/-) control versus CYP treatment (48 h), WT control versus VIP(-/-) control, and WT with CYP treatment (48 h) versus VIP(-/-) with CYP treatment (48 h).
T7 1033-1184 Sentence denotes The genes presented represent (1) greater than 1.5-fold change in either direction and (2) the p value is less than 0.05 for the comparison being made.
T8 1185-1286 Sentence denotes Several regulated genes were validated using enzyme-linked immunoassays including IL-1beta and CXCL1.
T9 1287-1611 Sentence denotes CYP treatment significantly (p < or = 0.001) increased expression of CXCL1 and IL-1beta in the urinary bladder of WT and VIP(-/-) mice, but expression in VIP(-/-) mice with CYP treatment was significantly (p < or = 0.001) greater (4.2- to 13-fold increase) than that observed in WT urinary bladder (3.6- to 5-fold increase).
T10 1612-1750 Sentence denotes The data suggest that in VIP(-/-) mice with bladder inflammation, inflammatory mediators are increased above that observed in WT with CYP.
T11 1751-1925 Sentence denotes This shift in balance may contribute to increased bladder dysfunction in VIP(-/-) mice with bladder inflammation and altered neurochemical expression in micturition pathways.

LitCoin-entities-OrganismTaxon-PD

Id Subject Object Predicate Lexical cue db_id
T1 104-108 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T3 277-281 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T5 496-500 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T7 575-580 OrganismTaxon denotes mouse NCBItxid:10090|NCBItxid:10088
T9 733-737 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T11 805-811 OrganismTaxon denotes binary NCBItxid:2775475
T12 1417-1421 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T14 1450-1454 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T16 1646-1650 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T18 1833-1837 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-154 Sentence denotes Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis.
T2 155-267 Sentence denotes Vasoactive intestinal polypeptide (VIP) is an immunomodulatory neuropeptide distributed in micturition pathways.
T3 268-414 Sentence denotes VIP(-/-) mice exhibit altered bladder function and neurochemical properties in micturition pathways after cyclophosphamide (CYP)-induced cystitis.
T4 415-572 Sentence denotes Given VIP's role as an anti-inflammatory mediator, we hypothesized that VIP(-/-) mice would exhibit enhanced inflammatory mediator expression after cystitis.
T5 573-799 Sentence denotes A mouse inflammatory cytokine and receptor RT2 profiler array was used to determine regulated transcripts in the urinary bladder of wild type (WT) and VIP(-/-) mice with or without CYP-induced cystitis (150 mg/kg; i.p.; 48 h).
T6 800-1032 Sentence denotes Four binary comparisons were made: WT control versus CYP treatment (48 h), VIP(-/-) control versus CYP treatment (48 h), WT control versus VIP(-/-) control, and WT with CYP treatment (48 h) versus VIP(-/-) with CYP treatment (48 h).
T7 1033-1184 Sentence denotes The genes presented represent (1) greater than 1.5-fold change in either direction and (2) the p value is less than 0.05 for the comparison being made.
T8 1185-1286 Sentence denotes Several regulated genes were validated using enzyme-linked immunoassays including IL-1beta and CXCL1.
T9 1287-1611 Sentence denotes CYP treatment significantly (p < or = 0.001) increased expression of CXCL1 and IL-1beta in the urinary bladder of WT and VIP(-/-) mice, but expression in VIP(-/-) mice with CYP treatment was significantly (p < or = 0.001) greater (4.2- to 13-fold increase) than that observed in WT urinary bladder (3.6- to 5-fold increase).
T10 1612-1750 Sentence denotes The data suggest that in VIP(-/-) mice with bladder inflammation, inflammatory mediators are increased above that observed in WT with CYP.
T11 1751-1925 Sentence denotes This shift in balance may contribute to increased bladder dysfunction in VIP(-/-) mice with bladder inflammation and altered neurochemical expression in micturition pathways.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
5099 26-38 DiseaseOrPhenotypicFeature denotes inflammatory MESH:D007249
5100 52-85 GeneOrGeneProduct denotes vasoactive intestinal polypeptide NCBIGene:22353
5101 96-99 GeneOrGeneProduct denotes VIP NCBIGene:22353
5102 104-108 OrganismTaxon denotes mice NCBITaxon:10090
5103 114-130 ChemicalEntity denotes cyclophosphamide MESH:D003520
5104 132-135 ChemicalEntity denotes CYP MESH:D003520
5105 145-153 DiseaseOrPhenotypicFeature denotes cystitis MESH:D003556
5106 155-188 GeneOrGeneProduct denotes Vasoactive intestinal polypeptide NCBIGene:22353
5107 190-193 GeneOrGeneProduct denotes VIP NCBIGene:22353
5108 268-271 GeneOrGeneProduct denotes VIP NCBIGene:22353
5109 277-281 OrganismTaxon denotes mice NCBITaxon:10090
5110 374-390 ChemicalEntity denotes cyclophosphamide MESH:D003520
5111 392-395 ChemicalEntity denotes CYP MESH:D003520
5112 405-413 DiseaseOrPhenotypicFeature denotes cystitis MESH:D003556
5113 421-424 GeneOrGeneProduct denotes VIP NCBIGene:22353
5114 443-455 DiseaseOrPhenotypicFeature denotes inflammatory MESH:D007249
5115 487-490 GeneOrGeneProduct denotes VIP NCBIGene:22353
5116 496-500 OrganismTaxon denotes mice NCBITaxon:10090
5117 524-536 DiseaseOrPhenotypicFeature denotes inflammatory MESH:D007249
5118 563-571 DiseaseOrPhenotypicFeature denotes cystitis MESH:D003556
5119 575-580 OrganismTaxon denotes mouse NCBITaxon:10090
5120 581-593 DiseaseOrPhenotypicFeature denotes inflammatory MESH:D007249
5121 724-727 GeneOrGeneProduct denotes VIP NCBIGene:22353
5122 733-737 OrganismTaxon denotes mice NCBITaxon:10090
5123 754-757 ChemicalEntity denotes CYP MESH:D003520
5124 766-774 DiseaseOrPhenotypicFeature denotes cystitis MESH:D003556
5125 853-856 ChemicalEntity denotes CYP MESH:D003520
5126 875-878 GeneOrGeneProduct denotes VIP NCBIGene:22353
5127 899-902 ChemicalEntity denotes CYP MESH:D003520
5128 939-942 GeneOrGeneProduct denotes VIP NCBIGene:22353
5129 969-972 ChemicalEntity denotes CYP MESH:D003520
5130 997-1000 GeneOrGeneProduct denotes VIP NCBIGene:22353
5131 1011-1014 ChemicalEntity denotes CYP MESH:D003520
5132 1267-1275 GeneOrGeneProduct denotes IL-1beta NCBIGene:16176
5133 1280-1285 GeneOrGeneProduct denotes CXCL1 NCBIGene:14825
5134 1287-1290 ChemicalEntity denotes CYP MESH:D003520
5135 1356-1361 GeneOrGeneProduct denotes CXCL1 NCBIGene:14825
5136 1366-1374 GeneOrGeneProduct denotes IL-1beta NCBIGene:16176
5137 1408-1411 GeneOrGeneProduct denotes VIP NCBIGene:22353
5138 1417-1421 OrganismTaxon denotes mice NCBITaxon:10090
5139 1441-1444 GeneOrGeneProduct denotes VIP NCBIGene:22353
5140 1450-1454 OrganismTaxon denotes mice NCBITaxon:10090
5141 1460-1463 ChemicalEntity denotes CYP MESH:D003520
5142 1637-1640 GeneOrGeneProduct denotes VIP NCBIGene:22353
5143 1646-1650 OrganismTaxon denotes mice NCBITaxon:10090
5144 1656-1676 DiseaseOrPhenotypicFeature denotes bladder inflammation MESH:D003556
5145 1678-1690 DiseaseOrPhenotypicFeature denotes inflammatory MESH:D007249
5146 1746-1749 ChemicalEntity denotes CYP MESH:D003520
5147 1801-1820 DiseaseOrPhenotypicFeature denotes bladder dysfunction MESH:D001745
5148 1824-1827 GeneOrGeneProduct denotes VIP NCBIGene:22353
5149 1833-1837 OrganismTaxon denotes mice NCBITaxon:10090
5150 1843-1863 DiseaseOrPhenotypicFeature denotes bladder inflammation MESH:D003556

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 145-153 DiseaseOrPhenotypicFeature denotes cystitis 0006032
T2 405-413 DiseaseOrPhenotypicFeature denotes cystitis 0006032
T3 563-571 DiseaseOrPhenotypicFeature denotes cystitis 0006032
T4 766-774 DiseaseOrPhenotypicFeature denotes cystitis 0006032

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 52-85 GeneOrGeneProduct denotes vasoactive intestinal polypeptide
T2 86-94 GeneOrGeneProduct denotes knockout
T3 155-188 GeneOrGeneProduct denotes Vasoactive intestinal polypeptide
T4 218-230 GeneOrGeneProduct denotes neuropeptide
T5 456-464 GeneOrGeneProduct denotes mediator
T6 537-545 GeneOrGeneProduct denotes mediator
T7 607-615 GeneOrGeneProduct denotes receptor
T8 1084-1088 GeneOrGeneProduct denotes fold
T9 1230-1236 GeneOrGeneProduct denotes enzyme
T10 1267-1275 GeneOrGeneProduct denotes IL-1beta
T11 1280-1285 GeneOrGeneProduct denotes CXCL1
T12 1356-1361 GeneOrGeneProduct denotes CXCL1
T13 1366-1374 GeneOrGeneProduct denotes IL-1beta
T14 1529-1533 GeneOrGeneProduct denotes fold
T15 1596-1600 GeneOrGeneProduct denotes fold

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 39-48 GeneOrGeneProduct denotes mediators
T2 52-85 GeneOrGeneProduct denotes vasoactive intestinal polypeptide
T3 86-94 GeneOrGeneProduct denotes knockout
T4 104-108 GeneOrGeneProduct denotes mice
T5 137-144 GeneOrGeneProduct denotes induced
T6 155-188 GeneOrGeneProduct denotes Vasoactive intestinal polypeptide
T7 218-230 GeneOrGeneProduct denotes neuropeptide
T8 277-281 GeneOrGeneProduct denotes mice
T9 397-404 GeneOrGeneProduct denotes induced
T10 456-464 GeneOrGeneProduct denotes mediator
T11 496-500 GeneOrGeneProduct denotes mice
T12 537-545 GeneOrGeneProduct denotes mediator
T13 607-615 GeneOrGeneProduct denotes receptor
T14 647-656 GeneOrGeneProduct denotes determine
T15 657-666 GeneOrGeneProduct denotes regulated
T16 667-678 GeneOrGeneProduct denotes transcripts
T17 733-737 GeneOrGeneProduct denotes mice
T18 758-765 GeneOrGeneProduct denotes induced
T19 780-782 GeneOrGeneProduct denotes mg
T20 1084-1088 GeneOrGeneProduct denotes fold
T21 1116-1123 GeneOrGeneProduct denotes and (2)
T22 1130-1135 GeneOrGeneProduct denotes value
T23 1193-1202 GeneOrGeneProduct denotes regulated
T24 1230-1236 GeneOrGeneProduct denotes enzyme
T25 1237-1243 GeneOrGeneProduct denotes linked
T26 1267-1275 GeneOrGeneProduct denotes IL-1beta
T27 1280-1285 GeneOrGeneProduct denotes CXCL1
T28 1356-1361 GeneOrGeneProduct denotes CXCL1
T29 1366-1374 GeneOrGeneProduct denotes IL-1beta
T30 1417-1421 GeneOrGeneProduct denotes mice
T31 1450-1454 GeneOrGeneProduct denotes mice
T32 1529-1533 GeneOrGeneProduct denotes fold
T33 1596-1600 GeneOrGeneProduct denotes fold
T34 1646-1650 GeneOrGeneProduct denotes mice
T35 1691-1700 GeneOrGeneProduct denotes mediators
T36 1756-1761 GeneOrGeneProduct denotes shift
T37 1833-1837 GeneOrGeneProduct denotes mice

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 26-38 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T2 145-153 DiseaseOrPhenotypicFeature denotes cystitis D003556
T3 405-413 DiseaseOrPhenotypicFeature denotes cystitis D003556
T4 443-455 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T5 524-536 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T6 563-571 DiseaseOrPhenotypicFeature denotes cystitis D003556
T7 581-593 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T8 766-774 DiseaseOrPhenotypicFeature denotes cystitis D003556
T9 1664-1676 DiseaseOrPhenotypicFeature denotes inflammation D007249
T10 1678-1690 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T11 1851-1863 DiseaseOrPhenotypicFeature denotes inflammation D007249

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 52-85 GeneOrGeneProduct denotes vasoactive intestinal polypeptide
T2 96-99 GeneOrGeneProduct denotes VIP
T3 155-188 GeneOrGeneProduct denotes Vasoactive intestinal polypeptide
T4 190-193 GeneOrGeneProduct denotes VIP
T5 218-230 GeneOrGeneProduct denotes neuropeptide
T6 268-271 GeneOrGeneProduct denotes VIP
T7 487-490 GeneOrGeneProduct denotes VIP
T8 594-615 GeneOrGeneProduct denotes cytokine and receptor
T9 724-727 GeneOrGeneProduct denotes VIP
T10 875-878 GeneOrGeneProduct denotes VIP
T11 939-942 GeneOrGeneProduct denotes VIP
T12 997-1000 GeneOrGeneProduct denotes VIP
T13 1267-1275 GeneOrGeneProduct denotes IL-1beta
T14 1280-1285 GeneOrGeneProduct denotes CXCL1
T15 1356-1361 GeneOrGeneProduct denotes CXCL1
T16 1366-1374 GeneOrGeneProduct denotes IL-1beta
T17 1408-1411 GeneOrGeneProduct denotes VIP
T18 1441-1444 GeneOrGeneProduct denotes VIP
T19 1637-1640 GeneOrGeneProduct denotes VIP
T20 1824-1827 GeneOrGeneProduct denotes VIP

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 145-153 DiseaseOrPhenotypicFeature denotes cystitis 0006032
T2 405-413 DiseaseOrPhenotypicFeature denotes cystitis 0006032
T3 563-571 DiseaseOrPhenotypicFeature denotes cystitis 0006032
T4 766-774 DiseaseOrPhenotypicFeature denotes cystitis 0006032

PMID_GLOBAL

Id Subject Object Predicate Lexical cue mondo_id
T1 145-153 DiseaseOrPhenotypicFeature denotes cystitis 0006032
T2 405-413 DiseaseOrPhenotypicFeature denotes cystitis 0006032
T3 563-571 DiseaseOrPhenotypicFeature denotes cystitis 0006032
T4 766-774 DiseaseOrPhenotypicFeature denotes cystitis 0006032

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 26-38 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T2 145-153 DiseaseOrPhenotypicFeature denotes cystitis D003556
T3 405-413 DiseaseOrPhenotypicFeature denotes cystitis D003556
T4 443-455 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T5 524-536 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T6 563-571 DiseaseOrPhenotypicFeature denotes cystitis D003556
T7 581-593 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T8 766-774 DiseaseOrPhenotypicFeature denotes cystitis D003556
T9 1664-1676 DiseaseOrPhenotypicFeature denotes inflammation DISEASE|D007249
T11 1678-1690 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T12 1801-1820 DiseaseOrPhenotypicFeature denotes bladder dysfunction DISEASE
T13 1851-1863 DiseaseOrPhenotypicFeature denotes inflammation DISEASE|D007249

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 145-153 DiseaseOrPhenotypicFeature denotes cystitis D003556
T2 405-413 DiseaseOrPhenotypicFeature denotes cystitis D003556
T3 563-571 DiseaseOrPhenotypicFeature denotes cystitis D003556
T4 766-774 DiseaseOrPhenotypicFeature denotes cystitis D003556
T5 1664-1676 DiseaseOrPhenotypicFeature denotes inflammation D007249
T6 1801-1820 DiseaseOrPhenotypicFeature denotes bladder dysfunction DISEASE
T7 1851-1863 DiseaseOrPhenotypicFeature denotes inflammation D007249

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 104-108 OrganismTaxon denotes mice
T2 277-281 OrganismTaxon denotes mice
T3 496-500 OrganismTaxon denotes mice
T4 575-580 OrganismTaxon denotes mouse
T5 733-737 OrganismTaxon denotes mice
T6 805-811 OrganismTaxon denotes binary
T7 1417-1421 OrganismTaxon denotes mice
T8 1450-1454 OrganismTaxon denotes mice
T9 1646-1650 OrganismTaxon denotes mice
T10 1833-1837 OrganismTaxon denotes mice

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 74-85 ChemicalEntity denotes polypeptide http://purl.obolibrary.org/obo/CHEBI_15841
T2 96-99 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T3 114-130 ChemicalEntity denotes cyclophosphamide D003520|http://purl.obolibrary.org/obo/CHEBI_4027|http://purl.obolibrary.org/obo/CHEBI_4026
T6 132-135 ChemicalEntity denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559|D003520
T8 177-188 ChemicalEntity denotes polypeptide http://purl.obolibrary.org/obo/CHEBI_15841
T9 190-193 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T10 268-271 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T11 374-390 ChemicalEntity denotes cyclophosphamide D003520|http://purl.obolibrary.org/obo/CHEBI_4027|http://purl.obolibrary.org/obo/CHEBI_4026
T14 392-395 ChemicalEntity denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559|D003520
T16 487-490 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T17 724-727 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T18 754-757 ChemicalEntity denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559|D003520
T20 853-856 ChemicalEntity denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559|D003520
T22 875-878 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T23 899-902 ChemicalEntity denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559|D003520
T25 939-942 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T26 969-972 ChemicalEntity denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559|D003520
T28 997-1000 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T29 1011-1014 ChemicalEntity denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559|D003520
T31 1287-1290 ChemicalEntity denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559|D003520
T33 1408-1411 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T34 1441-1444 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T35 1460-1463 ChemicalEntity denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559|D003520
T37 1637-1640 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T38 1746-1749 ChemicalEntity denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559|D003520
T40 1824-1827 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T40 1824-1827 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T38 1746-1749 ChemicalEntity denotes CYP D003520|http://purl.obolibrary.org/obo/CHEBI_38559
T37 1637-1640 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T35 1460-1463 ChemicalEntity denotes CYP D003520|http://purl.obolibrary.org/obo/CHEBI_38559
T34 1441-1444 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T33 1408-1411 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T31 1287-1290 ChemicalEntity denotes CYP D003520|http://purl.obolibrary.org/obo/CHEBI_38559
T29 1011-1014 ChemicalEntity denotes CYP D003520|http://purl.obolibrary.org/obo/CHEBI_38559
T28 997-1000 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T26 969-972 ChemicalEntity denotes CYP D003520|http://purl.obolibrary.org/obo/CHEBI_38559
T25 939-942 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T23 899-902 ChemicalEntity denotes CYP D003520|http://purl.obolibrary.org/obo/CHEBI_38559
T22 875-878 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T20 853-856 ChemicalEntity denotes CYP D003520|http://purl.obolibrary.org/obo/CHEBI_38559
T18 754-757 ChemicalEntity denotes CYP D003520|http://purl.obolibrary.org/obo/CHEBI_38559
T17 724-727 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T16 487-490 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T14 392-395 ChemicalEntity denotes CYP D003520|http://purl.obolibrary.org/obo/CHEBI_38559
T11 374-390 ChemicalEntity denotes cyclophosphamide http://purl.obolibrary.org/obo/CHEBI_4026|http://purl.obolibrary.org/obo/CHEBI_4027|D003520
T10 268-271 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T9 190-193 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T8 177-188 ChemicalEntity denotes polypeptide http://purl.obolibrary.org/obo/CHEBI_15841
T6 132-135 ChemicalEntity denotes CYP D003520|http://purl.obolibrary.org/obo/CHEBI_38559
T3 114-130 ChemicalEntity denotes cyclophosphamide http://purl.obolibrary.org/obo/CHEBI_4026|http://purl.obolibrary.org/obo/CHEBI_4027|D003520
T2 96-99 ChemicalEntity denotes VIP http://purl.obolibrary.org/obo/CHEBI_80331
T1 74-85 ChemicalEntity denotes polypeptide http://purl.obolibrary.org/obo/CHEBI_15841
T91871 1824-1827 GeneOrGeneProduct denotes VIP
T19 1637-1640 GeneOrGeneProduct denotes VIP
T32084 1441-1444 GeneOrGeneProduct denotes VIP
T98000 1408-1411 GeneOrGeneProduct denotes VIP
T46918 1366-1374 GeneOrGeneProduct denotes IL-1beta
T15 1356-1361 GeneOrGeneProduct denotes CXCL1
T75841 1280-1285 GeneOrGeneProduct denotes CXCL1
T13 1267-1275 GeneOrGeneProduct denotes IL-1beta
T12 997-1000 GeneOrGeneProduct denotes VIP
T95910 939-942 GeneOrGeneProduct denotes VIP
T18949 875-878 GeneOrGeneProduct denotes VIP
T50674 724-727 GeneOrGeneProduct denotes VIP
T93777 594-615 GeneOrGeneProduct denotes cytokine and receptor
T7 487-490 GeneOrGeneProduct denotes VIP
T71126 268-271 GeneOrGeneProduct denotes VIP
T5 218-230 GeneOrGeneProduct denotes neuropeptide
T4 190-193 GeneOrGeneProduct denotes VIP
T28423 155-188 GeneOrGeneProduct denotes Vasoactive intestinal polypeptide
T15628 96-99 GeneOrGeneProduct denotes VIP
T33665 52-85 GeneOrGeneProduct denotes vasoactive intestinal polypeptide
T18053 1851-1863 DiseaseOrPhenotypicFeature denotes inflammation D007249
T58854 1801-1820 DiseaseOrPhenotypicFeature denotes bladder dysfunction DISEASE
T66767 1664-1676 DiseaseOrPhenotypicFeature denotes inflammation D007249
T27495 766-774 DiseaseOrPhenotypicFeature denotes cystitis D003556
T62041 563-571 DiseaseOrPhenotypicFeature denotes cystitis D003556
T26767 405-413 DiseaseOrPhenotypicFeature denotes cystitis D003556
T14577 145-153 DiseaseOrPhenotypicFeature denotes cystitis D003556
T46312 1833-1837 OrganismTaxon denotes mice
T62412 1646-1650 OrganismTaxon denotes mice
T84417 1450-1454 OrganismTaxon denotes mice
T84733 1417-1421 OrganismTaxon denotes mice
T13710 805-811 OrganismTaxon denotes binary
T27804 733-737 OrganismTaxon denotes mice
T83307 575-580 OrganismTaxon denotes mouse
T19737 496-500 OrganismTaxon denotes mice
T77533 277-281 OrganismTaxon denotes mice
T46434 104-108 OrganismTaxon denotes mice